Ewing sarcoma arm advances to second lead-in safety dosing cohort in Sarcoma trial evaluating seclidemstat in combination with chemotherapy agents…
BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,…
Ji’an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and…
HENDERSON, Nev., Dec. 29, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (NASDAQ: PIII, or “P3”), a patient-centered and physician-led…
SEATTLE, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims…
WATERTOWN, Mass., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated…
Company developing STAT-201 as a novel therapy for immune modulation in treating pediatric patients with Crohn’s DiseaseFORT COLLINS, Colo., Dec.…
— H.C. Wainwright BIOCONNECT Virtual Conference — — 11th Annual LifeSci Partners Corporate Access Event — SAN DIEGO and TORONTO, Dec.…
Credit Facility provides the Company with liquidity to fund operations and organic growth initiativesTwo-year term provides additional financial flexibilityTORONTO, Dec.…
December 29, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the…